Trial Profile
Pilot, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, Dose Range Finding Study, to Evaluate the Tolerability and Safety of FXFM244 Antibiotic Foam and to Monitor Its Clinical Effect in Acne Vulgaris Patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Sep 2021
Price :
$35
*
At a glance
- Drugs Minocycline (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- 09 May 2016 Results published in a Foamix Pharmaceuticals media release.
- 11 Jun 2013 Results reported in a Foamix media release.
- 06 Jun 2013 Primary endpoint 'Lesion-healing' has been met, according to a Foamix media release.